524590 HEMORGANIC

Hemo Organic Share Price

₹12.40 -0.38 (-2.97%)

23 Dec, 2024 09:11

SIP TrendupStart SIP in HEMORGANIC

Start SIP

Performance

  • Low
  • ₹0
  • High
  • ₹0
  • 52 Week Low
  • ₹0
  • 52 Week High
  • ₹0
  • Open Price₹0
  • Previous Close₹0
  • Volume0

Investment Returns

  • Over 1 Month + 14.39%
  • Over 3 Month + 6.9%
  • Over 6 Month + 25.25%
  • Over 1 Year + 60.41%
SIP Lightning

Smart Investing Starts Here Start SIP with Hemo Organic for Steady Growth!

Invest Now

Hemo Organic Fundamentals Fundamentals refer to the financial data that companies report on a quarterly or annual basis.

Hemo Organic Financials

Hemo Organic Technicals

EMA & SMA

Current Price
₹12.40
-0.38 (-2.97%)
pointer
  • stock-down_img
  • Bullish Moving Average 16
  • stock-up_img
  • Bearish Moving Average 0
  • 20 Day
  • ₹11.45
  • 50 Day
  • ₹11.28
  • 100 Day
  • ₹11.20
  • 200 Day
  • ₹11.46

Resistance and Support

12.17 Pivot Speed
  • R3 14.78
  • R2 14.11
  • R1 12.84
  • S1 10.90
  • S2 10.23
  • S3 8.96

What's your outlook on Hemo Organic?

You can only vote for once

Hemo Organic Corporate Actions - Bonus, Splits, Dividends

Date Purpose Remarks
2024-12-26 Rights issue of Equity Shares
2024-10-28 Quarterly Results
2024-08-12 Quarterly Results
2024-05-29 Audited Results
2024-02-12 Quarterly Results

Hemo Organic F&O

Hemo Organic Shareholding Pattern

No data available.

About Hemo Organic

  • NSE Symbol
  • HEMORGANIC
  • BSE Symbol
  • 524590
  • ISIN
  • INE422G01015

Similar Stocks to Hemo Organic

Hemo Organic FAQs

Hemo Organic share price is ₹12 As on 23 December, 2024 | 08:57

The Market Cap of Hemo Organic is ₹4.3 Cr As on 23 December, 2024 | 08:57

The P/E ratio of Hemo Organic is -13.6 As on 23 December, 2024 | 08:57

The PB ratio of Hemo Organic is -13.6 As on 23 December, 2024 | 08:57

Open Free Demat Account

Be a part of 5paisa community - The first listed discount broker of India.

+91

By proceeding, you agree to all T&C*

footer_form

Disclaimer: Investment in securities market are subject to market risks, read all the related documents carefully before investing. For detailed disclaimer please Click here.

Q2FY23